Bayer increases production of anthrax antibiotic Cipro

The antibiotic Cipro has gone from relative obscurity to part of America’s new vocabulary in less than two weeks.

Bayer increases production of anthrax antibiotic Cipro

The antibiotic Cipro has gone from relative obscurity to part of America’s new vocabulary in less than two weeks.

Just 14 months since Bayer became the only company to receive Food and Drug Administration approval to produce the anthrax antibiotic, demand is exploding.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited